- Anthera Pharmaceuticals Inc ANTH shares dropped 66 percent to $0.683 after the company disclosed that the Phase 3 SOLUTION study with Sollpura has missed the primary endpoint.
- VisionChina Media Inc (ADR) VISN shares declined 12 percent to $4.99. VisionChina reported Q3 GAAP earnings of $0.63 per share on revenue of $12.8 million.
- ESSA Pharma Inc. EPIX shares tumbled 11.5 percent to $2.00. ESSA Pharma shares have dropped 43.50 percent over the past 52 weeks, while the S&P 500 index has gained 10.33 percent in the same period.
- Intrepid Potash, Inc. IPI shares fell 10.8 percent to $2.32.
- Northern Dynasty Minerals Ltd NAK shares declined 10.4 percent to $2.20. Northern Dynasty Minerals shares have jumped 778.57 percent over the past 52 weeks, while the S&P 500 index has gained 10.33 percent in the same period.
- ImmunoCellular Therapeutics Ltd IMUC shares dropped 10 percent to $1.97. ImmunoCellular Therapeutics shares have declined 85.59 percent over the past 52 weeks, while the S&P 500 index has gained 10.33 percent in the same period.
- EnteroMedics Inc ETRM shares fell 7.6 percent to $2.65.
- NVIDIA Corporation NVDA shares declined 3.8 percent to $112.92 after gaining 6.87 percent on Tuesday. Argus raised NVIDIA price target from $95 to $130.
- DryShips Inc. DRYS shares fell 3.4 percent to $3.87. On Tuesday, DryShips reported that it has entered into a $200 million common stock purchase agreement with Kalani Investments Limited.
- Franklin Covey Co. FC dropped 3.1 percent to $20.20. Barrington Research downgraded Franklin Covey from Outperform to Market Perform.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
